Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregg C Fonarow

Circulation

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Circulation|December 8, 2004
Heart failure disease management programs: not a class effectGregg C Fonarow
Circulation|September 6, 2014
Diabetes medications and heart failure: recognizing the riskGregg C Fonarow
Circulation|June 15, 2026
Sisyphean Task of Cardiovascular Prevention: Real Gains, Unequal ProgressBoback Ziaeian, Gregg C Fonarow
Circulation|August 30, 2017
Maximizing Cardiovascular Event Reduction by Expanding and Intensifying the TargetsBoback Ziaeian, Gregg C Fonarow
Circulation|July 30, 2008
Measures of obesity and outcomes after myocardial infarctionTamara B Horwich, Gregg C Fonarow
Circulation|November 15, 2017
Closing the Remaining Evidence Gap: Randomized Controlled Trial Data to Support Statin Therapy for Low-Density Lipoprotein ≥190 mg/dLKarol E Watson, Gregg C Fonarow
Circulation|March 13, 2026
The 2026 American College of Cardiology/American Heart Association Multisociety Guideline on the Management of Dyslipidemia: A More Precise-But More Complicated-Framework for Atherosclerotic Cardiovascular Disease Prevention and TreatmentKarol E Watson, Gregg C Fonarow
Circulation|August 5, 2024
Rapid and Intensive Guideline-Directed Medical Therapy for Heart Failure: 5 Core PrinciplesStephen J Greene, Javed Butler, Gregg C Fonarow
Circulation|April 17, 2023
STRONG-HF and Implementing Heart Failure Therapies: Godspeed … With CareJaved Butler, Khawaja M Talha, Gregg C Fonarow
Circulation|September 29, 2004
Genetic basis of atherosclerosis: part I: new genes and pathwaysAldons J Lusis, Alan M Fogelman, Gregg C Fonarow
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Circulation|December 8, 2004
Heart failure disease management programs: not a class effectGregg C Fonarow
Circulation|September 6, 2014
Diabetes medications and heart failure: recognizing the riskGregg C Fonarow
Circulation|June 15, 2026
Sisyphean Task of Cardiovascular Prevention: Real Gains, Unequal ProgressBoback Ziaeian, Gregg C Fonarow
Circulation|August 30, 2017
Maximizing Cardiovascular Event Reduction by Expanding and Intensifying the TargetsBoback Ziaeian, Gregg C Fonarow
Circulation|July 30, 2008
Measures of obesity and outcomes after myocardial infarctionTamara B Horwich, Gregg C Fonarow
Circulation|November 15, 2017
Closing the Remaining Evidence Gap: Randomized Controlled Trial Data to Support Statin Therapy for Low-Density Lipoprotein ≥190 mg/dLKarol E Watson, Gregg C Fonarow
Circulation|March 13, 2026
The 2026 American College of Cardiology/American Heart Association Multisociety Guideline on the Management of Dyslipidemia: A More Precise-But More Complicated-Framework for Atherosclerotic Cardiovascular Disease Prevention and TreatmentKarol E Watson, Gregg C Fonarow
Circulation|August 5, 2024
Rapid and Intensive Guideline-Directed Medical Therapy for Heart Failure: 5 Core PrinciplesStephen J Greene, Javed Butler, Gregg C Fonarow
Circulation|April 17, 2023
STRONG-HF and Implementing Heart Failure Therapies: Godspeed … With CareJaved Butler, Khawaja M Talha, Gregg C Fonarow
Circulation|September 29, 2004
Genetic basis of atherosclerosis: part I: new genes and pathwaysAldons J Lusis, Alan M Fogelman, Gregg C Fonarow
Pageof 10